Choroidal Neovascularization

Contributing journals to this collection:
JAMA & Archives Journals

Citations 1-10 of 118 total displayed.

Most recent content

Laboratory Sciences
Preclinical Evaluation of the Novel Small-Molecule Integrin 5β1 Inhibitor JSM6427 in Monkey and Rabbit Models of Choroidal Neovascularization

Grit Zahn; Dörte Vossmeyer; Roland Stragies; Margaret Wills; Corinne G. Wong; Karin U. Löffler; Anthony P. Adamis; Jochen Knolle
Arch Ophthalmol 2009; 127: 1329-1335. [Abstract] [Full text] [PDF]  

Past content

Clinical Sciences
Visual Acuity Outcomes Among Sham vs No-Treatment Controls From Randomized Trials

Barbara S. Hawkins; Neil M. Bressler; Sandra M. Reynolds
Arch Ophthalmol 2009; 127: 725-731. [Abstract] [Full text] [PDF] [ eTable ]  

Editorials
To Mask or Not to Mask

Roy W. Beck
Arch Ophthalmol 2009; 127: 801-802. [Extract] [Full text] [PDF]  

Laboratory Sciences
Suppression and Regression of Choroidal Neovascularization by the Multitargeted Kinase Inhibitor Pazopanib

Kyoichi Takahashi; Yoshitsugu Saishin; Yumiko Saishin; Andrew G. King; Robert Levin; Peter A. Campochiaro
Arch Ophthalmol 2009; 127: 494-499. [Abstract] [Full text] [PDF]  

Research Letters
Extensive Drusen in Type I Membranoproliferative Glomerulonephritis

Dennis P. Han; Stephen Sievers
Arch Ophthalmol 2009; 127: 577-579. [Extract] [Full text] [PDF]  

Clinical Sciences
Early Effects of Intravitreal Triamcinolone Acetonide on Inflammation and Proliferation in Human Choroidal Neovascularization

Olcay Tatar; Annemarie Adam; Kei Shinoda; Edwin Kaiserling; Vicky Boeyden; Carl Claes; Claus Eckardt; Tillmann Eckert; Grazia Pertile; Gabor B. Scharioth; Efdal Yoeruek; Peter Szurman; Karl Ulrich Bartz-Schmidt; Salvatore Grisanti
Arch Ophthalmol 2009; 127: 275-281. [Abstract] [Full text] [PDF] [ eFigures ]  

Clinical Sciences
Uveitic Foveal Atrophy: Clinical Features and Associations

Farzin Forooghian; Steven Yeh; Lisa J. Faia; Robert B. Nussenblatt
Arch Ophthalmol 2009; 127: 179-186. [Abstract] [Full text] [PDF]  

Clinical Trials
Surgical Removal vs Observation for Idiopathic or Ocular Histoplasmosis Syndrome–Associated Subfoveal Choroidal Neovascularization: Vision Preference Value Scale Findings From the Randomized SST Group H Trial: SST Report No. 17

Submacular Surgery Trials Research Group
Arch Ophthalmol 2008; 126: 1626-1632. [Abstract] [Full text] [PDF] [ eTable and eFigures ]  

Clinical Sciences
Combination of Photodynamic Therapy and Intraocular Triamcinolone for Exudative Age-Related Macular Degeneration and Long-Term Chorioretinal Macular Atrophy

Stefano Piermarocchi; Mauro Sartore; Giuseppe Lo Giudice; Veronica Maritan; Edoardo Midena; Tatiana Segato
Arch Ophthalmol 2008; 126: 1367-1374. [Abstract] [Full text] [PDF]  

Small Case Series
Toxoplasmosis-Associated Neovascular Lesions Treated Successfully With Ranibizumab and Antiparasitic Therapy

Joseph D. Benevento; Rama D. Jager; A. Gwendolyn Noble; Paul Latkany; William F. Mieler; Mari Sautter; Sanford Meyers; Marilyn Mets; Michael A. Grassi; Peter Rabiah; Kenneth Boyer; Charles Swisher; Rima McLeod; for the Toxoplasmosis Study Group
Arch Ophthalmol 2008; 126: 1152-1156. [Extract] [Full text] [PDF]  

[Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12